Paolo Andriollo

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

King's College London(Current)

Breast Cancer Now

Paolo Andriollo is an author at King's College London specializing in pharmacy, antibody-drug conjugate antibodies, and antibody-drug conjugate therapy.

ORCID

Publications per year

2017–2024

Publications

A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma

Ricarda M. Hoffmann, Silvia Crescioli, Silvia Mele et al. · Cancers · 2020 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth

Anthony Cheung, Alicia M. Chenoweth, Annelie Johansson et al. · Clinical Cancer Research · 2024 · 29 citations · Full text

Pharmacy, Oncology, Pharmacology +17

C8-Linked Pyrrolobenzodiazepine Monomers with Inverted Building Blocks Show Selective Activity against Multidrug Resistant Gram-Positive Bacteria

Paolo Andriollo, Charlotte K. Hind, Pietro Picconi et al. · ACS Infectious Diseases · 2017 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–3 of 3